Trial Outcomes & Findings for Ambispective, Multicentre, Open-label Study Evaluating the Clinical Outcomes of Foot Surgery Using SERF Medical Devices (NCT NCT05672069)
NCT ID: NCT05672069
Last Updated: 2025-01-13
Results Overview
The information will be collected through AOFAS (American Orthopaedic Foot and Ankle Society) score (\>80 points) at 12 months. This score is assessed using a questionnaire measuring the patient's pain, function and alignment of the foot. This score range from 0 (worst score) to 100 (best score). The score is interpreted as follows : Between 90-100 points : excellent results Between 80-89 points : good results Between 60-79 points : fair results Less than 60 points : poor results This score is composed of 3 sub-scores : (i) Pain score is ranging from 0 to 40 points ; Function score is ranging from 0 to 45 points ; Alignment is ranging from 0 to 15 points.
COMPLETED
124 participants
12 months
2025-01-13
Participant Flow
Participant milestones
| Measure |
Total Cohort
The description will be carried out on the whole population really included
|
|---|---|
|
Overall Study
STARTED
|
124
|
|
Overall Study
COMPLETED
|
121
|
|
Overall Study
NOT COMPLETED
|
3
|
Reasons for withdrawal
| Measure |
Total Cohort
The description will be carried out on the whole population really included
|
|---|---|
|
Overall Study
Implant removal
|
1
|
|
Overall Study
Lost to Follow-up
|
2
|
Baseline Characteristics
Ambispective, Multicentre, Open-label Study Evaluating the Clinical Outcomes of Foot Surgery Using SERF Medical Devices
Baseline characteristics by cohort
| Measure |
Total Cohort
n=124 Participants
The description will be carried out on the whole population really included
|
|---|---|
|
Age, Continuous
|
58.20 years
STANDARD_DEVIATION 12.89 • n=5 Participants
|
|
Sex: Female, Male
Female
|
99 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
25 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
French nationality
|
124 Participants
n=5 Participants
|
|
Operated foot side
Right
|
65 Number of foot
n=5 Participants
|
|
Operated foot side
Left
|
72 Number of foot
n=5 Participants
|
|
Foot position
Front of foot
|
123 Number of foot
n=5 Participants
|
|
Foot position
Middle of foot
|
6 Number of foot
n=5 Participants
|
|
Foot position
Front + Middle of foot
|
3 Number of foot
n=5 Participants
|
|
Foot position
Back of foot
|
5 Number of foot
n=5 Participants
|
|
Weight (kg)
|
66.72 Kg
STANDARD_DEVIATION 14.12 • n=5 Participants
|
|
Height of participant (cm)
|
165.85 cm
STANDARD_DEVIATION 7.23 • n=5 Participants
|
PRIMARY outcome
Timeframe: 12 monthsThe information will be collected through AOFAS (American Orthopaedic Foot and Ankle Society) score (\>80 points) at 12 months. This score is assessed using a questionnaire measuring the patient's pain, function and alignment of the foot. This score range from 0 (worst score) to 100 (best score). The score is interpreted as follows : Between 90-100 points : excellent results Between 80-89 points : good results Between 60-79 points : fair results Less than 60 points : poor results This score is composed of 3 sub-scores : (i) Pain score is ranging from 0 to 40 points ; Function score is ranging from 0 to 45 points ; Alignment is ranging from 0 to 15 points.
Outcome measures
| Measure |
Total Cohort
n=121 Participants
The description will be carried out on the whole population really included
|
|---|---|
|
Reduction of the Patient's Pain and Restoration of Walking
Preoperatively
|
42.46 points
Standard Deviation 15.25
|
|
Reduction of the Patient's Pain and Restoration of Walking
12 months
|
88.44 points
Standard Deviation 13.50
|
SECONDARY outcome
Timeframe: 12 monthsDetermination of the Kaplan-Meier type survival curve, with any revision as the endpoint whatever the cause. At each inflection point, a revision surgery with removal or revision surgery with removal or change of a component of the implant under consideration All causes of revision are considered. Patients who have died or been lost to follow-up will be included in the analysis.
Outcome measures
| Measure |
Total Cohort
n=121 Participants
The description will be carried out on the whole population really included
|
|---|---|
|
Survival Rate
|
89.3 percentage of implant survivorship
|
SECONDARY outcome
Timeframe: 12 monthsThe information will be collected through investigator's question : "on radiographic reading, is the foot bone consolidation satisfactory? : 4 answers are proposed: "total / partial / null / no information".
Outcome measures
| Measure |
Total Cohort
n=121 Participants
The description will be carried out on the whole population really included
|
|---|---|
|
Foot Bone Consolidation
Total
|
124 Number of foot
|
|
Foot Bone Consolidation
Partial
|
2 Number of foot
|
|
Foot Bone Consolidation
No consolidation
|
1 Number of foot
|
|
Foot Bone Consolidation
Not determined
|
7 Number of foot
|
SECONDARY outcome
Timeframe: 12 monthsThe information will be collected through patient's question : "Considering your expectations, are you satisfied with your operation?" 4 answers are proposed: "I am completely satisfied with the results of my operation results of my operation / My condition has not improved as much as I had hoped, but I but I would be willing to have the same operation for the same result / The operation improved my condition, but I would not be prepared to have the same operation for the same result / My condition is the same or worse than before my operation than before my operation".
Outcome measures
| Measure |
Total Cohort
n=121 Participants
The description will be carried out on the whole population really included
|
|---|---|
|
Patient Satisfaction
Very satisfied
|
103 Number of foot
|
|
Patient Satisfaction
Satisfied
|
20 Number of foot
|
|
Patient Satisfaction
Neither satisfied nor unsatisfied
|
6 Number of foot
|
|
Patient Satisfaction
Unsatisfied
|
5 Number of foot
|
SECONDARY outcome
Timeframe: Peroperative to 12 monthsType and occurrence of adverse events
Outcome measures
| Measure |
Total Cohort
n=121 Participants
The description will be carried out on the whole population really included
|
|---|---|
|
Adverse Event
Discomfort
|
8 Number of foot
|
|
Adverse Event
Pain
|
3 Number of foot
|
|
Adverse Event
Pseudoarthrosis
|
2 Number of foot
|
|
Adverse Event
Screw protrusion
|
2 Number of foot
|
|
Adverse Event
Persistent pain (consolidation with screw protrusion)
|
1 Number of foot
|
|
Adverse Event
Post-operative neurological disorders
|
1 Number of foot
|
|
Adverse Event
Stiff joint (hallux positioning problem)
|
1 Number of foot
|
|
Adverse Event
Loss of correction
|
1 Number of foot
|
|
Adverse Event
Scar disunion (poor effectiveness of meching)
|
1 Number of foot
|
|
Adverse Event
Locking default between locking screws/plate
|
1 Number of foot
|
Adverse Events
Total Cohort
Serious adverse events
| Measure |
Total Cohort
n=121 participants at risk
The adverse event occurred in an implanted foot.
|
|---|---|
|
Surgical and medical procedures
Persistent pain (consolidation with screw protrusion)
|
0.83%
1/121 • 12 months
|
|
Surgical and medical procedures
Arthrodesis pseudarthrosis
|
0.83%
1/121 • 12 months
|
|
Nervous system disorders
Post-operative neurological disorders
|
0.83%
1/121 • 12 months
|
|
Surgical and medical procedures
Screw protrusion
|
0.83%
1/121 • 12 months
|
|
Surgical and medical procedures
Pseudarthrosis
|
0.83%
1/121 • 12 months
|
Other adverse events
| Measure |
Total Cohort
n=121 participants at risk
The adverse event occurred in an implanted foot.
|
|---|---|
|
Injury, poisoning and procedural complications
Persistent / residual pain
|
2.5%
3/121 • 12 months
|
|
Surgical and medical procedures
Screws protrusion
|
0.83%
1/121 • 12 months
|
|
Injury, poisoning and procedural complications
Discomfort
|
6.6%
8/121 • 12 months
|
|
Surgical and medical procedures
Loss of correction
|
0.83%
1/121 • 12 months
|
|
Surgical and medical procedures
Scar disunion (poor effectiveness of meching)
|
0.83%
1/121 • 12 months
|
|
Surgical and medical procedures
Locking default between locking screws /plate
|
0.83%
1/121 • 12 months
|
|
Surgical and medical procedures
Stiff joint (hallux positioning problem)
|
0.83%
1/121 • 12 months
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place